Phreesia, Inc. (NYSE:PHR) Receives $32.58 Average PT from Analysts

Key Points

• Phreesia, Inc. has received a consensus recommendation of "Buy" from twelve research firms, with an average price target of $32.58.
• The company reported a revenue increase of 14.5% year-over-year, with the latest earnings showing less loss per share than analysts had estimated.
• Insider trading activity included sales by the Director and COO, indicating ongoing adjustments in ownership, with insiders holding 5.50% of the company's stock.

Shares of Phreesia, Inc. (NYSE:PHR - Get Free Report) have received a consensus recommendation of "Buy" from the twelve ratings firms that are presently covering the company, Marketbeat reports. Eleven research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $32.5833.

Several equities research analysts recently issued reports on the company. Mizuho assumed coverage on Phreesia in a report on Wednesday. They set an "outperform" rating and a $36.00 price target for the company. Canaccord Genuity Group cut their price target on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a report on Thursday, May 29th. Truist Financial boosted their price target on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, May 29th. Citigroup restated a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Finally, DA Davidson upgraded shares of Phreesia to a "strong-buy" rating in a report on Tuesday, July 22nd.

Insider Buying and Selling at Phreesia

In related news, insider Evan Roberts sold 45,147 shares of the business's stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $32.02, for a total transaction of $1,445,606.94. Following the transaction, the insider directly owned 727,768 shares in the company, valued at approximately $23,303,131.36. The trade was a 5.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Lisa Egbuonu-Davis sold 2,802 shares of the business's stock in a transaction dated Thursday, June 26th. The stock was sold at an average price of $27.67, for a total transaction of $77,531.34. Following the transaction, the director owned 22,037 shares in the company, valued at approximately $609,763.79. This trade represents a 11.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 119,874 shares of company stock valued at $3,587,618 in the last quarter. 5.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Principal Financial Group Inc. bought a new stake in shares of Phreesia in the 1st quarter worth approximately $1,623,000. Deutsche Bank AG raised its stake in shares of Phreesia by 95.9% in the fourth quarter. Deutsche Bank AG now owns 57,297 shares of the company's stock valued at $1,442,000 after buying an additional 28,047 shares during the period. Bessemer Group Inc. lifted its position in shares of Phreesia by 23.2% during the 1st quarter. Bessemer Group Inc. now owns 47,758 shares of the company's stock valued at $1,222,000 after buying an additional 8,978 shares during the last quarter. SG Americas Securities LLC purchased a new position in shares of Phreesia during the 1st quarter valued at $462,000. Finally, CWM LLC grew its stake in shares of Phreesia by 994.9% during the 1st quarter. CWM LLC now owns 4,040 shares of the company's stock worth $103,000 after acquiring an additional 3,671 shares during the period. 92.10% of the stock is owned by institutional investors.

Phreesia Stock Down 2.7%

Shares of PHR stock traded down $0.88 during trading hours on Friday, reaching $31.67. The company had a trading volume of 695,742 shares, compared to its average volume of 766,513. The company has a market cap of $1.88 billion, a price-to-earnings ratio of -42.79 and a beta of 0.71. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95. Phreesia has a 12 month low of $17.07 and a 12 month high of $32.76. The business has a fifty day simple moving average of $28.06 and a 200-day simple moving average of $26.50.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%.The business had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. During the same quarter in the prior year, the company posted ($0.05) earnings per share. Phreesia's revenue was up 14.5% compared to the same quarter last year. On average, research analysts expect that Phreesia will post -1.1 earnings per share for the current fiscal year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.